Rybelsus, the brand name for an oral semaglutide manufactured by Novo Nordisk, has come under scrutiny after patients have reported serious side effects
Understanding Tirzepatide Tirzepatide is an FDA-approved weight loss treatment, offered as an injection, that uniquely targets two hormonal pathways: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
GLP-1 short-term side effects include: Nausea Vomiting Diarrhea Constipation Headaches Fatigue Dizziness GLP-1 long-term side effects include: Ongoing and persistent irregular bowel movements Sluggish digestion Changes in gut comfort over time Impact on bone health and density Reduction in muscle mass Nutritional deficiencies Its important to note that long-term GLP-1 medication side effects have not been well-studied
The impact of selenium supplementation on mood
This transformative coaching process helped Caroline cultivate new habits and mindset strategies, ultimately enhancing her well-being and ability to manage lifes challenges. Achieving an incredible result Towards the end of the program, Caroline did a follow up SIBO test which was still positive